RecruitingNot applicableNCT07570212
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Studying Multiple system atrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking University First Hospital
- Principal Investigator
- Zhaoxia Wang, M.D.Peking University First Hospital
- Intervention
- TMS(device)
- Enrollment
- 50 enrolled
- Eligibility
- 30-80 years · All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- Peking University First Hospital, Beijing, Beijing Municipality, China
Collaborators
Changping Laboratory
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07570212 on ClinicalTrials.govOther trials for Multiple system atrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07519837Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-OmicsChina Medical University, China
- RECRUITINGPHASE3NCT07446894MSA-01 in Multiple System AtrophyTokyo University
- RECRUITINGPHASE1NCT07289477A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System AtrophyiRegene Therapeutics Co., Ltd.
- RECRUITINGPHASE2NCT07197866An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyTeva Branded Pharmaceutical Products R&D LLC
- ENROLLING BY INVITATIONNCT07081841AB-1005 Long-Term Follow-up StudyAskBio Inc
- RECRUITINGPHASE1, PHASE2NCT06831500Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.Julien Bally
- RECRUITINGEARLY PHASE1NCT06765733The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System AtrophyBeijing Tiantan Hospital
- RECRUITINGPHASE2NCT06868628A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)Tiziana Life Sciences LTD